- Antidepressants for preventing postnatal depression
- Antidepressants for smoking cessation
- Antidepressants for the negative symptoms of schizophrenia
- Antidepressants for treating depression in adults with end‐stage kidney disease treated with dialysis
- Antidepressants for treating depression in dementia
- Antidepressants plus benzodiazepines for adults with major depression
- Antidepressants versus placebo for depression in primary care
- Antidepressants versus placebo for people with bulimia nervosa
- Antidepressants versus placebo for the depressed elderly
- Antidepressants versus psychological treatments and their combination for bulimia nervosa
- Antiglucocorticoid treatments for mood disorders
- Antipsychotic drug treatment for elderly people with late‐onset schizophrenia
- Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum
- Antipsychotic medication for challenging behaviour in people with learning disability
- Antipsychotic medication for childhood‐onset schizophrenia
- Antipsychotic medication for early episode schizophrenia
- Antipsychotic medication for elderly people with schizophrenia
- Antipsychotic medication versus placebo for people with both schizophrenia and learning disability
- Antipsychotic medications for cocaine dependence
- Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.